| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/05/1999 | CA2238673A1 Novel aminopeptidase |
| 02/04/1999 | WO1999005270A2 Crustacean antimicrobial peptides, called penaiedines |
| 02/04/1999 | WO1999005269A2 Transcriptional silencer protein nrf |
| 02/04/1999 | WO1999005169A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis |
| 02/04/1999 | WO1999005165A1 Streptogramines, their preparation and compositions containing them |
| 02/04/1999 | WO1999005150A1 Nucleotide analog composition and synthesis method |
| 02/04/1999 | WO1999004810A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | WO1999004809A1 Pharmaceutical compositions containing lysostaphin alone or in combination with an antibiotic for the treatment of staphylococcal infections |
| 02/04/1999 | WO1999004804A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | WO1999004794A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | WO1999004789A1 Substituted aurone derivatives |
| 02/04/1999 | WO1999004774A2 Nucleotide analog compositions |
| 02/04/1999 | WO1999004628A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 02/04/1999 | CA2732570A1 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 02/04/1999 | CA2299514A1 Streptogramines, their preparation and compositions containing them |
| 02/04/1999 | CA2298526A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 02/04/1999 | CA2297753A1 Substituted aurone derivatives |
| 02/04/1999 | CA2297183A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | CA2296314A1 Cyclic amine modulators of chemokine receptor activity |
| 02/04/1999 | CA2239267A1 Novel compounds |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894859A2 Asparaginyl tRNA synthetase from Streptococcus pneumoniae |
| 02/03/1999 | EP0894857A2 SecA gene from Streptococcus pneumoniae |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894853A1 Transcriptional silencer protein NRF, nucleic acid molecules encoding it and their use |
| 02/03/1999 | EP0894806A1 Novel pheS |
| 02/03/1999 | EP0894805A1 Ribose substituted aromatic derivatives, their preparation and use as medicaments |
| 02/03/1999 | EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 02/03/1999 | EP0894134A1 Exodus chemokine materials and methods |
| 02/03/1999 | EP0894129A1 Short external guide sequences |
| 02/03/1999 | EP0894008A1 Method of producing immunogenic products and vaccines |
| 02/03/1999 | EP0894007A1 Porcine reproductive and respiratory syndrome vaccine |
| 02/03/1999 | EP0894006A1 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE THREONYL tRNA SYNTHETASE FAMILY |
| 02/03/1999 | EP0699202B1 Calanolide and related antiviral compounds, compositions, and uses thereof |
| 02/03/1999 | EP0576425B1 Method for inactivating sperm |
| 02/03/1999 | CN1207045A Nisin in combination with glycerol monolaurate active against helicobacter |
| 02/03/1999 | CN1206608A Prescription of medicine for curing superficial fungi and preparation process thereof |
| 02/03/1999 | CN1041934C Process for preparing and/or purifying bar acid or medicinal salt or ester thereof |
| 02/03/1999 | CN1041933C Diamine salts of clavulanic acid and their preparation process and use |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866694 Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates |
| 02/02/1999 | US5866684 Peptidyl inhibitors of viral proteases |
| 02/02/1999 | US5866606 Nutritional formulations containing water-miscible lipid derivatives as anti-microbial agents |
| 02/02/1999 | US5866589 Alkyl substituted piperadinyl and piperazinyl anti-AIDS compounds |
| 02/02/1999 | US5866583 Substituted 2,4-diaminopyrimidines |
| 02/02/1999 | US5866553 Immune protection against infection |
| 02/02/1999 | US5866541 Genetic engineering |
| 02/02/1999 | US5866539 Method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 02/02/1999 | US5866390 Leucyl tRNA synthetase polynucleotides of streptococcus |
| 02/02/1999 | US5866377 Aminooligosaccharide derivative and process for preparing the same |
| 02/02/1999 | US5866370 Polynucleotides and polypeptides of the m29 aminopeptidase family, hereinafter referred to as ?aminopeptidase.? |
| 02/02/1999 | US5866369 Amps |
| 02/02/1999 | US5866367 Gidb |
| 02/02/1999 | US5866366 gidB |
| 02/02/1999 | US5866365 Utilizing rnc polypeptides to screen for antibacterial compounds. |
| 02/02/1999 | US5866150 Antibacterially active extracts from the marine algae chaetoceros and methods of use |
| 02/02/1999 | US5866140 Type I surface antigen associated with staphylococcus epidermidis |
| 02/02/1999 | US5866135 Group A streptococcal polysaccharide immunogenic compositions and methods |
| 02/02/1999 | US5866134 Administering polysaccharide antibody and interleukins |
| 02/02/1999 | US5866132 Immunogenic oligosaccharide compositions |
| 02/02/1999 | US5866130 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 02/02/1999 | US5866125 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 02/02/1999 | US5866123 Gene encoding cationic amino acid transporter protein |
| 02/02/1999 | US5866117 Genetic engineering |
| 02/02/1999 | US5866105 Therapy for onychomycosis; topical applying nail varnish |
| 02/02/1999 | US5866074 Redox systems |
| 02/02/1999 | CA2130464C Topical aromatic releasing compositions |
| 02/02/1999 | CA1340379C Antimicrobial peptide, compositions containing same and uses thereof |
| 02/01/1999 | CA2238672A1 Seca |
| 01/29/1999 | CA2243882A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999003987A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | WO1999003885A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 01/28/1999 | WO1999003848A1 Thiazole derivatives, method for their production and use |
| 01/28/1999 | WO1999003499A1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 01/28/1999 | WO1999003497A1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 01/28/1999 | WO1999003489A2 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | WO1999003488A2 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | WO1999003452A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | WO1999003446A2 Antimicrobial cosmetic compositions |
| 01/28/1999 | WO1998047530A3 Coupling of unmodified proteins to haloacyl or dihaloacyl derivatized polysaccharides for the preparation of protein-polysaccharide vaccines |
| 01/28/1999 | WO1998044913A3 Compositions containing mkc-442 in combination with other antiviral agents |
| 01/28/1999 | WO1998040056A3 Pyrrolidine and thiazole derivatives with metallo-beta-lactamase inhibitory properties |
| 01/28/1999 | CA2298066A1 Methods and compositions for regulating nuclear trafficking of proteins |
| 01/28/1999 | CA2296736A1 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 01/28/1999 | CA2296620A1 Methods of removing residual solvent from nasal drug delivery compositions |
| 01/28/1999 | CA2296356A1 Use of an enzyme for the manufacture of an agent for controlling bacterial infection |
| 01/28/1999 | CA2294518A1 Biologically active peptides with reduced toxicity in animals and a method for preparing same |
| 01/28/1999 | CA2237155A1 A yak-1 related serine/threonine protein kinase-htlar33 |
| 01/27/1999 | EP0893507A1 Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment |
| 01/27/1999 | EP0893504A1 Polypeptide coded by the Kaposi sarcoma-associated virus (KSHV, HHV-8) and its uses in diagnostic and therapy |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893502A2 GreA from Staphylococcus aureus |
| 01/27/1999 | EP0893501A2 Ferrichrome transport atp-binding protein |
| 01/27/1999 | EP0893500A2 BmrU gene from Staphylococcus aureus |
| 01/27/1999 | EP0893499A2 Tetracycline resistance protein from Staphylococcus aureus |
| 01/27/1999 | EP0893498A2 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
| 01/27/1999 | EP0893496A2 Histidyl tRNA synthetase from Chlamydia trachomatis |